Biological Products, (No Diagnostic Substances)

94 US-listed companies SEC classification 2836 · all industries

How much this is one bet

40% of the closest matches for a typical Biological Products, (No Diagnostic Substances) company are other Biological Products, (No Diagnostic Substances) companies. That is moderate. The industry moves together to a degree, but individual companies still have plenty of their own story.

How the industry moves

Companies 94
Traded per day $5.4B
Median volatility 75.4%
Median beta vs SPY 1.43
Rate sensitivity -0.17
Volatility sensitivity -0.26

Measured from one year of daily returns. Rate sensitivity is the median correlation between a company's daily return and the daily change in the 10-year Treasury yield: positive means the industry tends to rise on days yields rise. It is a correlation, not a forecast, and a low number over one year is a statement about this year.

On the public record

Shares sold short 1.92B
Median days to cover 10.5
Insider purchases 98
Insider sales 449
Congressional trades 192
Institutions’ reported value $487.10B
Combined revenue as filed $92.17B

The companieslargest 60 by daily turnover

TickerCompanyTraded per dayBetaDays to cover
GILD Gilead Sciences, Inc. $885.1M 0.33 4.2
AMGN Amgen Inc. $872.2M 0.50 5.6
RVMD Revolution Medicines, Inc. $360.7M 1.10 4.7
MRNA Moderna, Inc. $334.4M 1.86 1.0
ARGX argenx SE $261.1M 0.30 3.9
BIIB Biogen Inc. $207.2M 0.30 8.7
TECH Bio-Techne Corp $201.4M 0.80 2.5
NBIX Neurocrine Biosciences, Inc. $193.0M 0.63 4.7
RGEN Repligen Corporation $144.5M 1.15 6.7
HALO Halozyme Therapeutics, Inc. $136.7M 0.55 8.7
EXEL Exelixis, Inc. $132.1M 0.57 14.9
TWST Twist Bioscience Corporation $125.4M 2.57 6.9
KRYS Krystal Biotech, Inc. $99.2M 0.75 15.3
QGEN Qiagen N.V. $95.3M 0.42 2.2
IBRX ImmunityBio, Inc. $83.0M 1.63 14.8
BNTX BioNTech SE $78.1M 0.91 1.0
CRSP CRISPR Therapeutics AG $77.8M 1.81 10.7
PCVX Vaxcyte, Inc. $66.3M 0.85 15.9
CGON CG Oncology, Inc. $62.2M 1.13 16.1
IOVA Iovance Biotherapeutics, Inc. $58.5M 1.21 5.3
BEAM Beam Therapeutics Inc. $57.1M 2.12 14.8
RXRX Recursion Pharmaceuticals, Inc. $56.0M 2.88 10.6
KYMR Kymera Therapeutics, Inc. $55.1M 0.80 16.8
TARS Tarsus Pharmaceuticals, Inc. $51.2M 0.59 9.8
ADPT Adaptive Biotechnologies Corporation $51.1M 1.67 6.4
SRRK Scholar Rock Holding Corporation $50.7M 0.96 15.4
RLAY Relay Therapeutics, Inc. $44.4M 1.43 16.7
IMVT Immunovant, Inc. $40.7M 1.35 14.1
DNLI Denali Therapeutics Inc. $36.3M 1.50 17.5
NVAX Novavax, Inc. $36.2M 1.77 8.6
BCRX BioCryst Pharmaceuticals, Inc. $36.2M 0.64 14.4
REPL Replimune Group, Inc. $33.9M 1.21 8.9
ADMA ADMA Biologics Inc $25.5M 0.78 13.9
KOD Kodiak Sciences Inc $23.0M 0.63 18.5
VCEL Vericel Corporation $21.3M 0.80 9.0
GLUE Monte Rosa Therapeutics, Inc. $20.3M 0.74 16.6
VOR Vor Biopharma Inc. $15.9M 1.64 10.4
IMCR Immunocore Holdings plc $15.1M 0.64 20.8
RGNX REGENXBIO Inc. $14.3M 2.00 4.9
TSHA Taysha Gene Therapies, Inc. $14.2M 1.74 19.4
VIR Vir Biotechnology, Inc. $14.1M 1.69 11.1
CADL Candel Therapeutics, Inc. $13.8M 1.96 9.2
ALLO Allogene Therapeutics, Inc. $13.6M 2.13 12.2
CGEM Cullinan Therapeutics, Inc. $13.2M 1.41 15.5
OTLK Outlook Therapeutics, Inc. $11.4M 1.01 1.6
CABA Cabaletta Bio, Inc. $9.9M 1.84 8.4
SANA Sana Biotechnology, Inc. $9.6M 2.38 16.1
PRME Prime Medicine, Inc. $9.5M 2.24 13.1
DNA Ginkgo Bioworks Holdings, Inc. Class A $9.2M 2.91 5.5
CCCC C4 Therapeutics, Inc. $9.1M 1.81 16.7
SLDB Solid Biosciences Inc. $8.7M 2.09 18.9
STRO Sutro Biopharma, Inc. $8.0M 1.21 8.5
FATE Fate Therapeutics, Inc. $7.4M 1.82 6.2
FDMT 4D Molecular Therapeutics, Inc. $7.3M 1.92 8.2
CMPX Compass Therapeutics, Inc. $6.9M 1.22 17.3
OCGN Ocugen, Inc. $6.9M 1.48 28.2
HUMA Humacyte, Inc. $6.8M 3.04 3.4
KYTX Kyverna Therapeutics, Inc. $6.6M 2.43 12.4
MGTX MeiraGTx Holdings plc $6.5M 1.62 4.7
LENZ LENZ Therapeutics, Inc. $5.4M 1.44 18.9

What “one bet” means, and how it is measured

For every security this site computes its closest matches across the whole market, by one-year daily-return correlation. Cohesion asks a simple question of that: of the ten closest matches for each company in this industry, what share are also in this industry?

A high number means the classification is doing real work — these companies genuinely move together, and the industry is closer to a single position than to a set of independent ones. Trucking, shipping, homebuilders and airlines sit at the top of that measure, which is what anyone who has held two of them would tell you.

A low number means the opposite: the SEC's code groups them, but the market does not. That is worth knowing before treating an industry label as a diversification plan.

Where these numbers come from

What is deliberately absent

No index, no sector return, no performance figure. Aggregating company returns into an industry return would be republishing the licensed price history in a thin disguise, and it would also be wrong — there is no defensible weighting to choose. The statistics here are all invariant to that problem: a median, a correlation, a count, or a sum of filed figures.

All industries, ranked · each company's own page is under security pages.